These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 27295491)
1. A surface modification of clozapine-loaded nanocapsules improves their efficacy: A study of formulation development and biological assessment. Vieira SM; Michels LR; Roversi K; Metz VG; Moraes BKS; Piegas EM; Freddo RJ; Gundel A; Costa TD; Burger ME; Colomé LM; Haas SE Colloids Surf B Biointerfaces; 2016 Sep; 145():748-756. PubMed ID: 27295491 [TBL] [Abstract][Full Text] [Related]
2. Clozapine-loaded nanocapsules improve antipsychotic activity in rats: building a sequential PopPK/PD model to discriminate nanocarriers in the preformulation step. Funguetto-Ribeiro AC; Maciel TR; Lunardi AG; Gomes DB; Ibarra M; Haas SE Pharm Res; 2023 Jul; 40(7):1751-1763. PubMed ID: 37349652 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of chitosan shielding effect on nano-carriers hydrophilicity and biodistribution. Ishak RA; Awad GA; Zaki NM; El-Shamy Ael-H; Mortada ND Carbohydr Polym; 2013 Apr; 94(1):669-76. PubMed ID: 23544589 [TBL] [Abstract][Full Text] [Related]
4. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. De Campos AM; Sánchez A; Gref R; Calvo P; Alonso MJ Eur J Pharm Sci; 2003 Sep; 20(1):73-81. PubMed ID: 13678795 [TBL] [Abstract][Full Text] [Related]
5. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree. Prego C; Torres D; Fernandez-Megia E; Novoa-Carballal R; Quiñoá E; Alonso MJ J Control Release; 2006 Apr; 111(3):299-308. PubMed ID: 16481062 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterisation of PEG modified chitosan nanocapsules loaded with thymoquinone. Vignesh Kumar SK; Renuka Devi P; Harish S; Hemananthan E IET Nanobiotechnol; 2017 Feb; 11(1):104-112. PubMed ID: 28476970 [TBL] [Abstract][Full Text] [Related]
9. Curcumin-loaded nanocapsules: Influence of surface characteristics on technological parameters and potential antimalarial activity. Santos RBD; Nakama KA; Pacheco CO; de Gomes MG; de Souza JF; de Souza Pinto AC; de Oliveira FA; da Fonseca AL; Varotti F; Fajardo AR; Haas SE Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111356. PubMed ID: 33254976 [TBL] [Abstract][Full Text] [Related]
10. Development of hydrophilic nanocarriers for the charged form of the local anesthetic articaine. Silva de Melo NF; Campos EV; Gonçalves CM; de Paula E; Pasquoto T; de Lima R; Rosa AH; Fraceto LF Colloids Surf B Biointerfaces; 2014 Sep; 121():66-73. PubMed ID: 24934456 [TBL] [Abstract][Full Text] [Related]
11. Hemocompatibility of poly(ɛ-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. Bender EA; Adorne MD; Colomé LM; Abdalla DSP; Guterres SS; Pohlmann AR Int J Pharm; 2012 Apr; 426(1-2):271-279. PubMed ID: 22322210 [TBL] [Abstract][Full Text] [Related]
12. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Parveen S; Sahoo SK Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969 [TBL] [Abstract][Full Text] [Related]
13. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy. Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354 [TBL] [Abstract][Full Text] [Related]
14. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative. Lollo G; Hervella P; Calvo P; Avilés P; Guillén MJ; Garcia-Fuentes M; Alonso MJ; Torres D Int J Pharm; 2015 Apr; 483(1-2):212-9. PubMed ID: 25681727 [TBL] [Abstract][Full Text] [Related]
15. Controlling Properties and Cytotoxicity of Chitosan Nanocapsules by Chemical Grafting. De Matteis L; Alleva M; Serrano-Sevilla I; García-Embid S; Stepien G; Moros M; de la Fuente JM Mar Drugs; 2016 Sep; 14(10):. PubMed ID: 27706041 [TBL] [Abstract][Full Text] [Related]
16. Clozapine linked to nanocapsules minimizes tissue and oxidative damage to biomolecules lipids, proteins and DNA in brain of rats Wistar. da Costa Güllich AA; Coelho RP; Pilar BC; Ströher DJ; Galarça LA; Vieira SM; da Costa Escobar Piccoli J; Haas SE; Manfredini V Metab Brain Dis; 2015 Jun; 30(3):695-702. PubMed ID: 25296867 [TBL] [Abstract][Full Text] [Related]
17. Encapsulation of clozapine in polymeric nanocapsules and its biological effects. Łukasiewicz S; Szczepanowicz K; Podgórna K; Błasiak E; Majeed N; Ogren SOÖ; Nowak W; Warszyński P; Dziedzicka-Wasylewska M Colloids Surf B Biointerfaces; 2016 Apr; 140():342-352. PubMed ID: 26774571 [TBL] [Abstract][Full Text] [Related]
18. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel. Lollo G; Rivera-Rodriguez GR; Bejaud J; Montier T; Passirani C; Benoit JP; García-Fuentes M; Alonso MJ; Torres D Eur J Pharm Biopharm; 2014 May; 87(1):47-54. PubMed ID: 24530693 [TBL] [Abstract][Full Text] [Related]
19. The interaction of clozapine loaded nanocapsules with the hCMEC/D3 cells - In vitro model of blood brain barrier. Łukasiewicz S; Błasiak E; Szczepanowicz K; Guzik K; Bzowska M; Warszyński P; Dziedzicka-Wasylewska M Colloids Surf B Biointerfaces; 2017 Nov; 159():200-210. PubMed ID: 28797970 [TBL] [Abstract][Full Text] [Related]
20. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies. Qu JB; Shao HH; Jing GL; Huang F Colloids Surf B Biointerfaces; 2013 Feb; 102():37-44. PubMed ID: 23000675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]